Skip to main content
VCbacked
Log inGet Started

Celaid Therapeutics

Hongo, Japan

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.

$3.6M raised
Oct 2025
Series B
BiotechnologyHealth CareManufacturingMedicalTherapeutics

Top Investors

UTEC - The University of Tokyo Edge Capital PartnersOsaka University Venture CapitalSBI GroupTsukuba Institute of ResearchNEDO

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Celaid Therapeutics

How much funding has Celaid Therapeutics raised?
Celaid Therapeutics has raised $3.6M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
Who are Celaid Therapeutics's investors?
Celaid Therapeutics's investors include UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, SBI Group, Tsukuba Institute of Research, NEDO.
Where is Celaid Therapeutics headquartered?
Celaid Therapeutics is headquartered in Hongo, Japan.
What does Celaid Therapeutics do?
Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.
What stage is Celaid Therapeutics at?
Celaid Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Celaid Therapeutics — Funding & Investors." VCBacked, October 7, 2025, https://www.vcbacked.co/company/celaid-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Celaid Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/celaid-therapeutics
Wikipedia (cite web)
{{cite web |title=Celaid Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/celaid-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K